David Rosenbaum - Mar 29, 2023 Form 4 Insider Report for ARDELYX, INC. (ARDX)

Role
Chief Development Officer
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for David Rosenbaum
Stock symbol
ARDX
Transactions as of
Mar 29, 2023
Transactions value $
-$13,888
Form type
4
Date filed
3/31/2023, 06:50 PM
Previous filing
Feb 24, 2023
Next filing
May 25, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARDX Common Stock Sale -$13.9K -3K -2.58% $4.63 113K Mar 29, 2023 By Wife F1, F2
holding ARDX Common Stock 376K Mar 29, 2023 Direct
holding ARDX Common Stock 77.6K Mar 29, 2023 Family Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the adjusted total which includes the purchase of 3,000 shares under the Ardelyx Employee Stock Purchase Plan on February 28, 2023.
F2 The shares are directly held by the Reporting Person's wife.
F3 The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.